Compare FBRX & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRX | TALK |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 872.7M |
| IPO Year | 2017 | 2020 |
| Metric | FBRX | TALK |
|---|---|---|
| Price | $77.00 | $5.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $67.00 | $6.42 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.30 | ★ 300.00 |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $27,600,000.00 |
| Revenue This Year | N/A | $26.02 |
| Revenue Next Year | N/A | $21.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.09 |
| 52 Week Low | $10.18 | $2.49 |
| 52 Week High | $77.20 | $5.25 |
| Indicator | FBRX | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 84.34 | 58.26 |
| Support Level | $26.85 | $5.19 |
| Resistance Level | $77.20 | N/A |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | -1.75 | 0.00 |
| Stochastic Oscillator | 83.33 | 100.00 |
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.